Page last updated: 2024-12-05

2-chloro-4-nitroaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-chloro-4-nitroaniline: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8492
CHEMBL ID1893710
SCHEMBL ID532698
SCHEMBL ID15630259
MeSH IDM0193948

Synonyms (59)

Synonym
einecs 204-502-2
ortho-chloro-para-nitroaniline
ccris 2648
brn 0638657
hsdb 5405
nsc 3548
ai3-09084
ocpna
nsc-3548
aniline, 2-chloro-4-nitro-
1-amino-2-chloro-4-nitrobenzene
4-nitro-2-chloroaniline
nsc3548
2-chloro-4-nitrobenzenamine
benzenamine, 2-chloro-4-nitro-
o-chloro-p-nitroaniline
121-87-9
2-chloro-4-nitroaniline
wln: zr bg dnw
inchi=1/c6h5cln2o2/c7-5-3-4(9(10)11)1-2-6(5)8/h1-3h,8h
STK358782
2-chloro-4-nitroaniline, 99%
NCGC00164027-01
AC-7419
2-chloro-4-nitro-phenylamine
AKOS000120340
A804801
2-chloranyl-4-nitro-aniline
(2-chloro-4-nitro-phenyl)-amine
unii-xsa3zx337b
xsa3zx337b ,
4-12-00-01675 (beilstein handbook reference)
2-chloro-4-nitrophenylamine
FT-0611787
AM20060498
AE-562/40244765
SCHEMBL532698
chloro-4-nitroaniline, 2-
1-amino-2-chloro-4-nitrobenzene [hsdb]
2-chloro-4-nitro-aniline
2-chlor-4-nitroanilin
dtxcid201973
dtxsid4021973 ,
tox21_303921
cas-121-87-9
NCGC00357167-01
CHEMBL1893710
SCHEMBL15630259
BS-3940
CS-W020588
J-508775
F0001-0350
mfcd00007665
(2-chloro-4-nitrophenyl)amine
Z57126995
2-chloro-4-nitroaniline,(s)
Q2597946
EN300-17939
D88095

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The results are discussed with respect to the physiology of the organisms and the bioavailability of toxicants, as well as to the consequences these results may have under field conditions."( The influence of suspended particles on the acute toxicity of 2-chloro-4-nitro-aniline, cadmium, and pentachlorophenol on the valve movement response of the zebra mussel (Dreissena polymorpha).
Borcherding, J; Wolf, J, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency89.35840.007215.758889.3584AID1224835
AR proteinHomo sapiens (human)Potency29.18920.000221.22318,912.5098AID1259243; AID1259247; AID588516
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency44.69250.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency54.48270.000417.946075.1148AID1346795
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.61130.001530.607315,848.9004AID1224841
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency19.95260.001019.414170.9645AID588537
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.66 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index41.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]